CARGO Therapeutics Inc (CRGX)

Currency in USD
4.49
-0.01(-0.11%)
Real-time Data·
CRGX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected tomorrow
CRGX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.484.51
52 wk Range
3.0025.45
Key Statistics
Prev. Close
4.49
Open
4.5
Day's Range
4.48-4.51
52 wk Range
3-25.45
Volume
338.4K
Average Volume (3m)
1.44M
1-Year Change
-67.86%
Book Value / Share
5.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CRGX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.33
Upside
+18.78%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

CARGO Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

CARGO Therapeutics Inc Company Profile

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.

Compare CRGX to Peers and Sector

Metrics to compare
CRGX
Peers
Sector
Relationship
P/E Ratio
−1.0x−3.1x−0.5x
PEG Ratio
−0.060.010.00
Price/Book
0.9x2.7x2.6x
Price / LTM Sales
-58.1x3.3x
Upside (Analyst Target)
11.4%184.4%43.3%
Fair Value Upside
Unlock4.5%6.9%Unlock

Analyst Ratings

0 Buy
4 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 5.33
(+18.78% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-1.77 / -1.17
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CRGX Income Statement

People Also Watch

2.335
CRDF
-2.30%
2.45
INMB
-4.34%
1.9406
DARE
+1.07%
35.21
APGE
-0.51%
4.28
BIOA
-1.15%

FAQ

What Stock Exchange Does CARGO Therapeutics Trade On?

CARGO Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for CARGO Therapeutics?

The stock symbol for CARGO Therapeutics is "CRGX."

What Is the CARGO Therapeutics Market Cap?

As of today, CARGO Therapeutics market cap is 217.16M.

What Is CARGO Therapeutics's Earnings Per Share (TTM)?

The CARGO Therapeutics EPS (TTM) is -4.63.

When Is the Next CARGO Therapeutics Earnings Date?

CARGO Therapeutics will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is CRGX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has CARGO Therapeutics Stock Split?

CARGO Therapeutics has split 0 times.

How Many Employees Does CARGO Therapeutics Have?

CARGO Therapeutics has 167 employees.

What is the current trading status of CARGO Therapeutics (CRGX)?

As of 11 Aug 2025, CARGO Therapeutics (CRGX) is trading at a price of 4.49, with a previous close of 4.49. The stock has fluctuated within a day range of 4.48 to 4.51, while its 52-week range spans from 3.00 to 25.45.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.